LON:EKF - Ekf Diagnostics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 33.10 -0.65 (-1.93 %)
(As of 05/19/2019 11:28 AM ET)
Previous CloseGBX 33.10
Today's RangeGBX 33.40 - GBX 33.70
52-Week RangeGBX 24 - GBX 41.10
Volume76,142 shs
Average Volume206,806 shs
Market Capitalization£150.30 million
P/E Ratio15.05
Dividend YieldN/A
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Africa, and internationally. It offers DiaSpect Tm, an hemoglobin analyzer; DiaSpect Hemoglobin T Low to determine low levels of hemoglobin in plasma and serum specimens, aqueous solutions, or stored or banked erythrocytes; Hemo Control, a point-of-care hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a centrifuge that provides a hematocrit reading for six blood samples. The company also provides glucose and lactate analyzers, such as Biosen C-Line GP+, C-Line Clinic, and S-Line Lab+; Quo-Lab A1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test A1c for the monitoring and management of diabetes in a point-of-care setting; and STAT-Site M Beta-hydroxybutyrate analyzer for use in the determination of BHB in serum or plasma in ketosis patients. In addition, it offers Creamatocrit Plus, an analyzer for detecting the lipid concentration and calorific density in mothers' milk; True20 and QuPID pregnancy tests for testing urine only or urine and serum; SensPoint, a lactate analyzer with docking station; and Lactate Scout+, a lactate analyzer. Further, the company offers Altair 240, an analyzer calibrated to run the Stanbio chemistry range of reagents; reagents, such as BHB for detecting ketosis, Procalcitonin for detecting sepsis, and glycated serum protein for use in the diagnosis and screening of diabetes; and contract manufacturing services, as well as services and distributes third party company products. It sells its products directly to GP surgeries, sports and diabetes clinics, blood banks, hospitals, laboratories, and government agencies, as well as through a network of distributors. The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom.

Receive EKF News and Ratings via Email

Sign-up to receive the latest news and ratings for EKF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Appliances & Equipment



Sales & Book Value

Annual Sales£42.54 million
Cash FlowGBX 2.18 per share
Book ValueGBX 14 per share



Market Cap£150.30 million
Next Earnings DateN/A
OptionableNot Optionable

Ekf Diagnostics (LON:EKF) Frequently Asked Questions

What is Ekf Diagnostics' stock symbol?

Ekf Diagnostics trades on the London Stock Exchange (LON) under the ticker symbol "EKF."

Has Ekf Diagnostics been receiving favorable news coverage?

News articles about EKF stock have trended positive recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Ekf Diagnostics earned a news sentiment score of 2.2 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days.

Who are some of Ekf Diagnostics' key competitors?

What other stocks do shareholders of Ekf Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ekf Diagnostics investors own include ERBA Diagnostics (ERBA), Telford Homes (TEF), Kirkland Lake Gold (KLG), ASOS (ASC), Advanced Computer Software Group (asw), Boohoo Group (BOO), SolGold (SOLG), Newmont Goldcorp (NEM), Avesoro Resources (ASO) and Arcontech Group (ARC).

Who are Ekf Diagnostics' key executives?

Ekf Diagnostics' management team includes the folowing people:
  • Mr. Julian Huw Baines, CEO & Exec. Director (Age 54)
  • Mr. Richard Anthony Evans, COO, Fin. Director & Exec. Director (Age 62)
  • Mr. Andrew Webb, Chief Exec. Officer of Ekf Molecular
  • Salim Hamir, Company Sec.

How do I buy shares of Ekf Diagnostics?

Shares of EKF and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Ekf Diagnostics' stock price today?

One share of EKF stock can currently be purchased for approximately GBX 33.10.

How big of a company is Ekf Diagnostics?

Ekf Diagnostics has a market capitalization of £150.30 million and generates £42.54 million in revenue each year.

What is Ekf Diagnostics' official website?

The official website for Ekf Diagnostics is http://www.ekfdiagnostics.com/.

How can I contact Ekf Diagnostics?

Ekf Diagnostics' mailing address is Avon HSE, 19 Stanwell Road, PENARTH, CF64 2EZ, United Kingdom. The company can be reached via phone at +44-29-20710570.

MarketBeat Community Rating for Ekf Diagnostics (LON EKF)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  287 (Vote Outperform)
Underperform Votes:  160 (Vote Underperform)
Total Votes:  447
MarketBeat's community ratings are surveys of what our community members think about Ekf Diagnostics and other stocks. Vote "Outperform" if you believe EKF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EKF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/19/2019 by MarketBeat.com Staff

Featured Article: Price-Sales Ratio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel